{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T22:30:48Z","timestamp":1781735448086,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T00:00:00Z","timestamp":1706486400000},"content-version":"am","delay-in-days":727,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jinf.2021.11.020","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T17:35:02Z","timestamp":1638293702000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Susceptibility of epidemic viruses to neuraminidase inhibitors and treatment-emergent resistance in the Japanese 2019-20 influenza season"],"prefix":"10.1016","volume":"84","author":[{"given":"Naoki","family":"Tani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seizaburo","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ikematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2021.11.020_bib0001","unstructured":"Antiviral resistance surveillance in Japan (as of March 15 2017,). Available at: https:\/\/www.niid.go.jp\/niid\/en\/influ-resist-e\/7129-flu-r-e20170315.html. Accessed May 26, 2021."},{"issue":"4","key":"10.1016\/j.jinf.2021.11.020_bib0002","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s40506-016-0085-5","article-title":"Japanese surveillance systems and treatment for influenza","volume":"8","author":"Zaraket","year":"2016","journal-title":"Curr Treat Options Infect Dis"},{"key":"10.1016\/j.jinf.2021.11.020_bib0003","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2147\/IDR.S105473","article-title":"Drug resistance in influenza A virus: the epidemiology and management","volume":"10","author":"Hussain","year":"2017","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jinf.2021.11.020_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104718","article-title":"Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2017\u20132018","volume":"175","author":"Takashita","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jinf.2021.11.020_bib0005","unstructured":"Antiviral resistance surveillance in Japan (as of March 25, 2021). Available at: https:\/\/www.niid.go.jp\/niid\/en\/influ-resist-e\/10258-flu-r-e20210325.html. Accessed May 26, 2021."},{"issue":"8","key":"10.1016\/j.jinf.2021.11.020_bib0006","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jiac.2020.03.001","article-title":"In vitro neuraminidase inhibitory concentration (IC(50)) of four neuraminidase inhibitors in the Japanese 2018-19 season: comparison with the 2010-11 to 2017-18 seasons","volume":"26","author":"Ikematsu","year":"2020","journal-title":"J Infect Chemother"},{"issue":"3","key":"10.1016\/j.jinf.2021.11.020_bib0007","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jiac.2018.08.012","article-title":"High genetic stability in MDCK-SIAT1 passaged human in fl uenza viruses","volume":"25","author":"Matsumoto","year":"2019","journal-title":"J Infect Chemother"},{"issue":"10","key":"10.1016\/j.jinf.2021.11.020_bib0008","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1128\/JCM.36.10.2990-2995.1998","article-title":"Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses","volume":"36","author":"Stockton","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2021.11.020_bib0009","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jviromet.2014.04.016","article-title":"Real-time RT-PCR assays for discriminating influenza B virus Yamagata and victoria lineages","volume":"205","author":"Nakauchi","year":"2014","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.jinf.2021.11.020_bib0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1128\/AAC.00333-08","article-title":"CS-8958, a prodrug of the new neuraminidase inhibitor R-125489, shows long-acting anti-influenza virus activity","volume":"53","author":"Yamashita","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"39","key":"10.1016\/j.jinf.2021.11.020_bib0011","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility \u2013 Geneva, November 2011 and June 2012","volume":"87","year":"2012","journal-title":"Relev Epidemiol Hebd"},{"issue":"9","key":"10.1016\/j.jinf.2021.11.020_bib0012","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jiac.2018.04.013","article-title":"Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate in the 2016\/17 Japanese influenza season; comparison with the 2011\/12 to 2015\/16 seasons","volume":"24","author":"Ikematsu","year":"2018","journal-title":"J Infect Chemother"},{"issue":"19","key":"10.1016\/j.jinf.2021.11.020_bib0013","doi-asserted-by":"crossref","first-page":"10309","DOI":"10.1128\/JVI.01109-09","article-title":"Single-reaction genomic amplification accelerates sequencing and vaccine production for classical and Swine origin human influenza a viruses","volume":"83","author":"Zhou","year":"2009","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.jinf.2021.11.020_bib0014","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/JCM.03265-13","article-title":"Universal influenza B virus genomic amplification facilitates sequencing, diagnostics, and reverse genetics","volume":"52","author":"Zhou","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.jinf.2021.11.020_bib0015","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/irv.12624","article-title":"Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan","volume":"13","author":"Chong","year":"2019","journal-title":"Influenza Other Respir Viruses"},{"issue":"25","key":"10.1016\/j.jinf.2021.11.020_bib0016","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1056\/NEJMp058291","article-title":"Oseltamivir resistance\u2013disabling our influenza defenses","volume":"353","author":"Moscona","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jinf.2021.11.020_bib0017","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.vaccine.2016.11.084","article-title":"Effect of seasonal vaccination on the selection of influenza A\/H3N2 epidemic variants","volume":"35","author":"Chong","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.jinf.2021.11.020_bib0018","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/irv.12534","article-title":"Five years of monitoring for the emergence of oseltamivir resistance in patients with influenza A infections in the influenza resistance information study","volume":"12","author":"Lina","year":"2018","journal-title":"Influenza Other Respir Viruses"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321005831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445321005831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:34:17Z","timestamp":1759008857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445321005831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0163445321005831"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2021.11.020","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibility of epidemic viruses to neuraminidase inhibitors and treatment-emergent resistance in the Japanese 2019-20 influenza season","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2021.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}